Search

A clinical trial, NCT06600932, has been launched to investigate the effects of transcranial magnetic stimulation (TMS) on visual outcomes in patients after cataract surgery. The trial aims to determine if TMS can improve visual outcomes in these patients by comparing it to a sham-controlled treatment. Participants will undergo TMS treatment or the sham treatment for five consecutive days and visit the clinic every two weeks for checkups and tests. The trial is not yet recruiting and is expected to be completed by October 2026. [Extracted from the article]

A clinical trial, NCT06612190, has been launched to investigate whether transcranial magnetic stimulation (TMS) can improve visual outcomes in patients with visual impairment. The trial aims to compare TMS treatment to a control group that does not receive TMS to determine if TMS is effective in improving visual outcomes. Participants will undergo TMS treatment or no effective TMS for five consecutive days and visit the clinic every two weeks for checkups and tests. The trial is currently not recruiting participants and is expected to be completed by October 2027. [Extracted from the article]

Keywords: Biological Products; Cancer; Emerging Technologies; Health and Medicine; Immunization; Nanoparticles; Nanotechnology; Oncology; Public Health; Vaccination; Vaccines EN Biological Products Cancer Emerging Technologies Health and Medicine Immunization Nanoparticles Nanotechnology Oncology Public Health Vaccination Vaccines 55 55 1 08/14/23 20230814 NES 230814 2023 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- New research on vaccines is the subject of a new report. For more information on this research see: Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation. [Extracted from the article]